Anebulo Pharmaceuticals, Inc.

ANEB
$0.38 (+ $0.00 + 0.00%)
Last updated: 2026-07-06 10:59 UTC
ANEB Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS0345691036
CUSIP034569103
Market Price0.38
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-0.22
Market Cap$48.9M
Book Value0.24
Price to Book5.021
Beta-0.87
52w High3.42
52w Low0.9
Next Earnings DateN/A

Anebulo Pharmaceuticals, Inc. trades under ticker ANEB on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US0345691036, CUSIP 034569103.

About the Company
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. The company's lead product candidate is the selonabant, a small-molecule antagonist of cannabinoid binding receptor type-1(CB1), which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Lakeway, Texas.
Price History